Bristol $300 Mil. DoJ Settlement Includes Separation OF CEO/Chairman Roles

Bristol-Myers Squibb board member James Robinson will take on additional corporate governance oversight responsibilities, including meeting with execs prior to analyst calls, as the newly-appointed chairman